Hydroxychloroquine for lupus: How does Plaquenil® work?

Why is hydroxychloroquine so widely used in lupus?

Lupus is a complex autoimmune disease

Lupus is a chronic autoimmune disease in which the immune system becomes dysregulated and attacks certain tissues in the body. This inflammation can affect different parts of the body, including the skin, joints, kidneys, heart, lungs, and nervous system.

The course of lupus is often unpredictable, with periods of remission and inflammatory flare-ups of varying intensity. This variability explains why treatment usually relies on long-term maintenance therapies designed to stabilise the disease over time.

This is where hydroxychloroquine plays a major role.

Hydroxychloroquine acts on immune system activity

Initially developed to treat malaria, hydroxychloroquine also has immunomodulatory properties, meaning that it helps regulate certain immune system reactions.

In lupus, the medication acts in particular on certain cells involved in chronic inflammation and the production of autoantibodies. It does not completely “suppress” immunity, but it helps reduce excessive activation of the immune system.

This gradual action helps limit disease activity and reduce the risk of flare-ups.

A treatment considered a cornerstone of care

Today, hydroxychloroquine is recommended for most patients with systemic lupus, unless there is a specific contraindication. Several studies have shown that it reduces the risk of flare-ups, improves long-term survival, and helps limit certain complications.

The treatment may also have beneficial effects on fatigue, joint pain, and certain skin symptoms.

For many patients, Plaquenil® therefore becomes a maintenance treatment, incorporated into daily life for several years.

How does Plaquenil® work in the body?

Its effect is gradual, not immediate

Unlike some anti-inflammatory medications that act quickly, hydroxychloroquine often takes several weeks, or even several months, to reach its full effectiveness.

This delay can feel unsettling at the beginning of treatment. Some patients may feel that “nothing is changing” during the first few weeks. However, the medication is gradually acting in the background on inflammatory mechanisms.

This slow action explains why it is considered a maintenance treatment, rather than a treatment intended to provide immediate relief during an acute flare-up.

The treatment helps prevent lupus flare-ups

One of the main goals of Plaquenil® is to reduce the frequency and intensity of inflammatory flare-ups.

Over the long term, this stabilisation can have an important impact on quality of life. Some people describe their disease as becoming more "predictable", with fewer sudden fluctuations in fatigue, pain, or skin symptoms.

Preventing flare-ups is also essential to limit potential damage to certain organs, such as the kidneys or the cardiovascular system.

It may help reduce the use of certain other treatments

In some cases, hydroxychloroquine helps reduce the prolonged use of corticosteroids. This is particularly important because corticosteroids, although effective, can cause many long-term side effects.

Plaquenil® is therefore often part of a broader strategy to control the disease while limiting long-term exposure to heavier treatments.

This approach reflects an increasingly personalised view of lupus care.

What are the side effects and monitoring requirements?

Most patients tolerate the treatment well

Hydroxychloroquine is generally considered a well-tolerated treatment, especially compared with some more powerful immunosuppressants.

The most common side effects mainly involve mild digestive problems, such as nausea, abdominal pain, or loss of appetite, which are often temporary at the start of treatment.

Some people also report headaches, skin sensitivity, or changes in skin pigmentation.

However, each patient’s experience can vary greatly.

Why is eye monitoring necessary?

The most closely monitored side effect concerns the retina, a structure at the back of the eye. In rare cases, prolonged use can lead to retinal toxicity.

This risk remains low when recommended doses are followed, but it justifies regular ophthalmological follow-up.

This monitoring can sometimes worry patients when they start treatment. However, serious complications remain rare, and current recommendations generally allow any abnormalities to be detected early.

For many people living with lupus, these eye exams gradually become part of their long-term medical follow-up.

Care that takes place over time

Because lupus is a chronic disease, a person’s relationship with treatment often evolves over the years. Some patients go through periods of doubt, frustration, or worry about taking a medication every day.

Over time, many also describe gradually finding a balance: learning to recognise the signs of a flare-up, fitting medical appointments into their routine, and adapting their pace of life when fatigue becomes more present.

The treatment does not “cure” lupus, but it often helps make the disease more stable and more compatible with personal, professional, or family plans.

Living with lupus on hydroxychloroquine day to day

Treatment is part of a broader approach

Plaquenil® is usually only one part of lupus care. Medical follow-up, stress management, sleep, adapted physical activity, and sun protection also play an important role in keeping the disease balanced.

This broader approach often becomes clearer over time, as patients gradually learn to better understand their own flare-up triggers and physical limits.

Fatigue remains a major issue for many patients

Even with treatment, some people continue to experience significant fatigue. This fatigue can be difficult to explain to others because it fluctuates and is often invisible.

Treatment often helps improve disease stability, but it does not always make all symptoms disappear.

This is a reminder that living with lupus often involves gradually adapting daily life, with some periods that feel easier and others that are more difficult.

The outlook for lupus has changed considerably

Over recent decades, lupus care has improved significantly. Treatments such as hydroxychloroquine have helped reduce serious complications and improve life expectancy.

Many people living with lupus today continue their studies, work, travel, or build a family life, even if the condition sometimes requires adjustments.

Lupus remains a complex chronic disease, but therapeutic advances now allow many patients to achieve better long-term stability.

FAQ

What is Plaquenil® used for in lupus?

Plaquenil® helps reduce immune system activity, prevent lupus flare-ups, and stabilise the disease over the long term.

How long does hydroxychloroquine take to work?

The treatment works gradually. The first effects may appear after several weeks, or sometimes several months.

What are the side effects of Plaquenil®?

The most common side effects are digestive. Regular eye monitoring is also recommended because of a rare risk of retinal toxicity.

Can you take Plaquenil® for life?

In many patients with lupus, hydroxychloroquine is used for many years under regular medical supervision.

Why do the eyes need to be monitored with hydroxychloroquine?

In rare cases, the treatment can affect the retina after prolonged exposure. Eye exams allow any abnormalities to be detected early.

If you found this article helpful, feel free to give it a “Like” and share your thoughts and questions with the community in the comments below!

Take care!